WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'0201 Infant (under 12 months) mortality rate: 892
GDP / capita (US$): 2'0811 Child (under 5 years) mortality rate: 1502

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 12'825  12'448  12'080  11'721  11'371  8'301  5'952  4'513 
Births 590  579  569  558  546  426  304  225 
Surviving infants 534  523  512  501  490  378  267  195 
Pop. less than 5 years 2'457  2'406  2'353  2'292  2'239  1'683  1'177  859 
Pop. less than 15 years 6'208  6'050  5'889  5'724  5'575  4'065  2'826  2'034 
Female 15-49 years 2'796  2'699  2'607  2'522  2'434  1'767  1'277  1'001 

Number of reported case

(Click for retrospective incidence data for Chad)
Diphtheria
Japanese encephalitis
Measles 226  120  8'650  194  165  3'546  7'226 
Mumps
Pertussis
Polio* 17  132  27  64  60 
Rubella
Rubella (CRS)
Tetanus (neonatal) 176  225  215  279  146  142  738 
Tetanus (total) 176  225  215  146  1'603 
Yellow fever 48  122  79 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Chad)
Vaccine year result method % card seen                                                
BCG 2011  68  EPI   41  83  79  79  84  72  50 
DTP1 2011  55  EPI   41  98  93  94  100  95  45 
DTP3 2011  42  EPI   41  80  72  70  83  75  28  20 
HepB_BD         
HepB3 2011  42  EPI   41  80  72  70  83  75 
Hib3 2011  42  EPI   41  80  72  70  83  75 
JapEnc         
MCV 2011  54  EPI   41  79  69  79  84  87  42 
MCV2         
PCV1         
PCV3         
Pol3 2011  52  EPI   41  80  73  67  75  68  29  16 
Rota1         
Rota_last         
Rubella1         
TT2plus 2009  38  MICS   21  78  70  60  77  61  12 
PAB         
VAD1         
YFV 2011  45  EPI   41  79  70  80  82  79  36 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Chad)
BCG 62  63  53  58  46  49  59 
DTP1 55  55  55  55  45  45  44 
DTP3 48  45  33  39  24  36  20 
HepB3 48  45  33  39  24 
HepB_BD
Hib3 48  45  33  39  24 
MCV 59  64  54  46  36  28  32 
MCV2
PAB 50  43  60  60  60  39  14 
PCV3
Pol3 56  56  40  43  32  30  20 
Rota_last
YFV 49  53  45  41  32  28 

Number of districts in the country 70  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 43
From 80 to 89% 17
From 50 to 79% 23
Less than 50% 16
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV Yes From January 2015
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2017  2013 - 2017  2008 - 2012  2008-2012  2008-2012  2008 - 2012  2008 - 2012 
Nº of districts with microplans that include activities to raise immunization coverage number 70  61  61  37  35  51  32 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  Yes       

System performance

Total Nº districts in country number 70  61  61  61  61  61  54 
Nº districts with DTP3 coverage >=80% number 42  32  19  33  32 
% of districts with DTP3 coverage >=80% From 0 to 100% 60  52  31  54  52  13 
Nº districts with measles (MCV1) coverage >=95% number 21  24  14  20  18  11   
% of districts with MCV1 coverage >=95% From 0 to 100% 30  39  23  33  30  18   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No  No  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 41  24  11  65  45    80 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.